Immunonutrition in elective gastrointestinal surgery patients

Area of Science:

• Clinical Nutrition
• Surgical Oncology
• Gastroenterology

Background:

• Previous studies suggested perioperative immunonutrition may reduce infectious complications post-gastrointestinal surgery.
• The efficacy of immunonutrition in major gastrointestinal surgery remains under investigation.

Purpose of the Study:

• To evaluate the impact of perioperative immunonutrition on postoperative morbidity, infection rates, mortality, and hospital stay.
• To determine if routine immunonutrition is beneficial for patients undergoing major gastrointestinal surgery.

Main Methods:

• A randomized controlled trial involving 100 patients undergoing elective gastrointestinal surgery.
• Patients received either specialized oral immunonutrition (arginine, omega-3 fatty acids, RNA) or conventional nutrition/IV fluids.
• Intervention involved supplementation five days before and five days after surgery.

Main Results:

• Infectious complications occurred in 18% of patients in both the immunonutrition and conventional groups.
• Overall complication rates were 28% for immunonutrition and 24% for conventional groups.
• No significant differences were observed in complication rates, mortality, or length of hospital stay between the groups.

Conclusions:

• Routine perioperative immunonutrition is not beneficial for patients undergoing major gastrointestinal surgery.
• The study did not support the use of this specific immunonutrition regimen to improve outcomes.